<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>isfcppharmaspire</PublisherName>
      <JournalTitle>Pharmaspire</JournalTitle>
      <PISSN>C</PISSN>
      <EISSN>o</EISSN>
      <Volume-Issue>Volume 15, Issue 04, 2023</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>October-December</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2024</Year>
        <Month>02</Month>
        <Day>17</Day>
      </PubDate>
      <ArticleType>Pharmacognosy</ArticleType>
      <ArticleTitle>Herbal medicines utilized in the management of COVID-19</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>264</FirstPage>
      <LastPage>271</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Deeksha</FirstName>
          <LastName>Adhikari</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Naresh Kumar Rangra</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI>10.56933/Pharmaspire.2023.15139</DOI>
      <Abstract>COVID-19 management is becoming a popular topic of research among drug developers, researchers, and scientists because the coronavirus is a rapidly dividing virus that spreads by injecting its genome into the genes of other organisms and multiplying there. As a result, it depends on other organisms for its growth which makes it more challenging to eradicate the disease-causing agent. The Coronaviridae family of viruses includes the enveloped, positive-sense single-stranded RNA virus known as coronaviruses (CoV). Different species of the CoV family cause infections of the upper respiratory tract and gastrointestinal tract in mammals and birds. People typically get the common cold from it, but it can also result in complications such as pneumonia and SARS. The more well-known severe acute respiratory syndrome coronavirus, which in 2003 posed a serious threat with a high mortality rate, is one of the recognized human coronaviruses (HCoV), along with HCoV-229E, -OC43, -NL63, -HKU1, and others. The Middle East respiratory syndrome CoV, a sixth kind of HCoV infection with a high mortality rate, was described by the World Health Organization in 2012. Numerous herbal extracts have been used to treat clinical indications related to the respiratory system as ayurvedic medicine has a treatment for a wide variety of illnesses and complex medical diseases. Therefore, a variety of herbal remedies and purely natural substances can greatly help in the creation of novel antiviral treatments. Tinospora cordifolia, Curcuma longa, Ocimum basilicum, and Allium sativum are a few herbs utilized in COVID-19. In this work, an effort has been made to assess problems and potential treatment with the help of herbal medicine.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Antiviral, Immunomodulatory, Medicinal plants, SARS-CoV-2</Keywords>
      <URLs>
        <Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=15073&amp;title=Herbal medicines utilized in the management of COVID-19</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>1. Alamri MA, Tahir Ul Qamar M, Mirza MU, Alqahtani SM,  Froeyen M, Chen LL. Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches. J Pharm Anal 2020;10:546-59.&#13;
2. Ng K, Poon BH, Kiat Puar TH, Shan Quah JL, Loh WJ, Wong YJ, et al. COVID-19 and the risk to health care workers: A case report. Ann Intern Med 2020;172:766-7. &#13;
3. Gonzand;aacute;lez-Bustamante B. Evolution and early government responses to COVID-19 in South America. World Dev 2021;137:105180.&#13;
4. Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multicenter study in Wenzhou city, Zhejiang, China. J Infect Dis 2020;80:388-93.&#13;
5. Kumar D, Jahan S, Khan A, Siddiqui AJ, Redhu NS, Wahajuddin, et al. Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19. Mol Neurobiol 2021;58:3417-34.&#13;
6. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020;27:325-8.&#13;
7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China novel coronavirus investigating and research team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.&#13;
8. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44.&#13;
9. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents 2020;55:105948.&#13;
10. Adhikari B, Sahu N. COVID-19 into chemical science perspective: Chemical preventive measures and drug development. ChemistrySelect 2021;6:2010-28.&#13;
11. Ebob OT, Babiaka SB, Ntie-Kang F. Natural products as potential lead compounds for drug discovery against SARS-CoV-2. Nat Prod Bioprospect 2021;11:611-28.&#13;
12. Maldonado C, Paniagua-Zambrana N, Bussmann RW, Zenteno-Ruiz FS, Fuentes AF. The importance of medicinal plants, their taxonomy and the search for a cure for the disease caused by the Coronavirus (COVID-19). Ecol Bolivia 2020;55:1-5.&#13;
13. Siddiqui AJ, Danciu C, Ashraf SA, Moin A, Singh R, Alreshidi M, et al. Plants-derived biomolecules as potent antiviral phytomedicines: New insights on ethnobotanical evidences against coronaviruses. Plants (Basel) 2020;9:1244.&#13;
14. Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: A review of their mechanisms, pros and cons. Evid Based Complement Alternat Med 2020;2020:2560645.&#13;
15. He J, Tao H, Yan Y, Huang SY, Xiao Y. Molecular mechanism of evolution and human infection with SARS-CoV-2. Viruses 2020;12:428.&#13;
16. Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, et al. Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: What is known? Fertil Steril 2020;113:1140-9.&#13;
17. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:177.&#13;
18. Kapoor R, Sharma B, Kanwar SS. Antiviral phytochemicals: An overview. Biochem Physiol Open Access 2017;6:220.&#13;
19. Matos AD, Caetano BC, de Almeida Filho JL, Martins JS, de Oliveira MG, Sousa TD,et al.Identification of hypericin as a candidate repurposed therapeutic agent for COVID- 19 and its potential anti-SARS-CoV-2 activity. Front Microbiol 2022;13:828984.&#13;
20. Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of ayurvedic rasayana therapy in brain aging. Biogerontology 2008;9:369-74.&#13;
21. Maurya VK, Kumar S, Bhatt ML, Saxena SK. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. J Biomol Struct Dyn 2022;40:1719-35.&#13;
22. Ang L, Song E, Lee HW, Lee MS. Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials. J Clin Med 2020;9:1583.&#13;
23. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020;83:770-803.&#13;
24. Enquist LW, Editors of the journal of virology. Virology in the 21st century. J Virol 2009;83:5296-308.&#13;
25. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol 2020;92:424-32.&#13;
26. Hussain W, Haleem KS, Khan I, Tauseef I, Qayyum S, Ahmed B, et al. Medicinal plants: A repository of antiviral metabolites. Future Virol 2017;12:299-308.&#13;
27. Akram M, Tahir IM, Shah SM, Mahmood Z, Altaf A, Ahmad K, et al. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother Res 2018;32:811-22.&#13;
28. Denaro M, Smeriglio A, Barreca D, De Francesco C, Occhiuto C, Milano G, et al. Antiviral activity of plants and their isolated bioactive compounds: An update. Phytother Res 2020;34:742-68.&#13;
29. Maldonado C, Barnes CJ, Cornett C, Holmfred E, Hansen SH, Persson C, et al. Phylogeny predicts the quantity of antimalarial alkaloids within the iconic yellow cinchona bark (Rubiaceae: Cinchona calisaya). Front Plant Sci 2017;8:391.&#13;
30. Abolghasemi E, Moosa-Kazemi SH, Davoudi M, Reisi A, Satvat MT. Comparative study of chloroquine and quinine on malaria rodents and their effects on the mouse testis. Asian Pac J Trop Biomed 2012;2:311-4.&#13;
31. D’Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, et al. The use of antimalarial drugs against viral infection. Microorganisms 2020;8:85.&#13;
32. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005;2:69.&#13;
33. Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949.&#13;
34. Ishfaq M, Chen C, Bao J, Zhang W, Wu Z, Wang J, et al. Baicalin ameliorates oxidative stress and apoptosis by restoring mitochondrial dynamics in the spleen of chickens via the opposite modulation of NF-and;kappa;B and Nrf2/HO-1 signalling pathway during Mycoplasma gallisepticum infection. Poult Sci 2019;98:6296-310.&#13;
35. Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004;31:69-75.&#13;
36. Deng YF, Aluko RE, Jin Q, Zhang Y, Yuan LJ. Inhibitory activities of baicalin against renin and angiotensinconverting enzyme. Pharm Biol 2012;50:401-6.&#13;
37. Yu MS, Lee J, Lee JM, Kim Y, Chin YW, Jee JG, et al. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorganic Med Chem Lett 2012;22:4049-54.&#13;
38. Song JW, Long JY, Xie L, Zhang LL, Xie QX, Chen HJ, et al. Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: A review. Chin Med 2020;15:102.&#13;
39. Silva JK, Figueiredo PL, Byler KG, Setzer WN. Essential oils as antiviral agents. Potential of essential oils to treat SARS-CoV-2 infection: An in-silico investigation. Int J Mol Sci 2020;21:3426.&#13;
40. Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarand;atilde;es FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci 2012;367:3364-78.&#13;
41. Mabou Tagne A, Pacchetti B, Sodergren M, Cosentino M, Marino F. Cannabidiol for viral diseases: Hype or hope? Cannabis Cannabinoid Res 2020;5:121-31.&#13;
42. Jahan I, Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk J Biol 2020;44:228-41.&#13;
43. Omosa LK, Midiwo JO, Kuete V. Curcuma longa. In: Therapeutic Potential against Metabolic, Inflammatory, Infectious and Systemic Diseases. Cambridge, MA: Academic Press; 2017. p. 425-35. &#13;
44. Utomo RY, Ikawati M, Meiyanto E. Revealing the potency of Citrus and galangal constituents to Halt SARS-CoV-2 infection. Preprints 2020:2020030214. doi: 10.20944/ preprints202003.0214.v1&#13;
45. Meiyanto E, Larasati YA. The chemopreventive activity of Indonesia medicinal plants targeting on hallmarks of cancer. Adv Pharm Bull 2019;9:219-30.&#13;
46. Tiwari A, Mahadik KR, Gabhe SY. Piperine: A comprehensive review of methods of isolation, purification, and biological properties. Med Drug Discov 2020;7:100027.&#13;
47. Priya NC, Saravana K. Antiviral activities and cytotoxicity assay of seed extracts of Piper longum and Piper nigrum on human cell lines. Int J Pharm Sci Rev Res 2017;44:197-202.&#13;
48. Rajagopal K, Byran G, Jupudi S, Vadivelan R. Activity of phytochemical constituents of black pepper, ginger, and garlic against coronavirus (COVID-19): An in-silico approach. Int J Health Allied Sci 2020;9:S43-50.&#13;
49. Kumar A. Molecular docking of natural compounds from Tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 protein targets. Research square 2020:1-9.&#13;
50. Shree P, Mishra P, Selvaraj C, Singh SK, Chaube R, Garg N, et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study. J Biomol Struct Dyn 2022;40:190-203.&#13;
51. Sagar VK, Kumar AH. Efficacy of natural compounds from Tinospora cordifolia against SARS-CoV-2 protease, surface glycoprotein and RNA polymerase. Biol Eng Med Sci Rep 2020;6:6-8.&#13;
52. Sun W, Shahrajabian MH, Cheng Q. Anise (Pimpinella anisum L.), a dominant spice and traditional medicinal herb for both food and medicinal purposes. Cogent Biol 2019;5:1-25.&#13;
53. Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. J Biomol Struct Dyn 2021;39:3092-8.&#13;
54. Dong X, Fu J, Yin X, Cao S, Li X, Lin L, et al. Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother Res 2016;30:1207-18.&#13;
55. Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 2007;74:92-101.&#13;
56. Jantan I, Ahmad W, Bukhari SN. Plant-derived immunomodulators: An insight on their preclinical evaluation and clinical trials. Front Plant Sci 2015;6:655.&#13;
57. Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators inspired by nature: A review on curcumin and Echinacea. Molecules 2018;23:2778.&#13;
58. Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res 2021;35:864-76.&#13;
59. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2.&#13;
60. Cascella M, Rajnik M, Aleem A, Dulebohn S, Di NR. Features, evaluation, and treatment of coronavirus (COVID-19). In: Stat Pearls. Treasure Island, FL: StatPearls Publishing; 2023.&#13;
61. Das K. Herbal plants as immunity modulators against COVID-19: A primary preventive measure during home quarantine. J Herb Med 2022;32:100501.&#13;
62. Shah AS, Gunjal MA, Juvekar AR. Immuno stimulatory activity of aqueous extract of Azadirachta indica flowers on specific and non-specific immune response. J Nat Remedies 2009;9:35-42.&#13;
63. Sreeramulu D, Raghunath M. Antioxidant activity and phenolic content of roots, tubers and vegetables commonly consumed in India. Food Res Int 2009;43:1017-20.&#13;
64. Wang YF, Wang XY, Ren Z, Qian CW, Li YC, Kaio K, et al. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Antiviral Res 2009;84:150-8.&#13;
65. Tiwari R, Chakraborty S, Saminathan M, Dhama K, Singh SV. Ashwagandha (Withania somnifera): Role in afe guarding health, immunomodulatory effects, combating infections andtherapeutic applications: A review. J Biol Sci 2014;14:77-94.&#13;
66. Gautam M, Diwanay SS, Gairola S, Shinde YS, Jadhav SS, Patwardhan BK. Immune response modulation to DPT vaccine by aqueous extract of Withania somnifera in experimental system. Int Immunopharmacol 2004;4:841-9.&#13;
67. Akhtar S. Use of Tinospora cordifolia in HIV infection. Indian J Pharmacol 2010;42:57.&#13;
68. Aranha I, Clement F, Venkatesh YP. Immunostimulatory properties of the major protein from the stem of the Ayurvedic medicinal herb, guduchi (Tinospora cordifolia). J Ethnopharmacol 2012;139:366-72.&#13;
69. Thakar A, Panara K, Shah H, Kalsariya B, Ruparel S, Jain N, et al. Guduchi Ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-andafter study. Eur J Integr Med 2022;53:102131.&#13;
70. Panaro MA, Corrado A, Benameur T, Paolo CF, Cici D, Porro C. The emerging role of curcumin in the modulation of TLR-4 signaling pathway: Focus on neuroprotective and anti-rheumatic properties. Int J Mol Sci 2020;21:2299.&#13;
71. Gupta H, Gupta M, Bhargava S. Potential use of turmeric in COVID-19. Clin Exp Dermatol 2020;45:902-3.&#13;
72. Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 2009;83:165-70.&#13;
73. Hudson J, Vimalanathan S. Echinacea-a source of potent antivirals for respiratory virus infections. Pharmaceuticals 2011;4:1019-31.&#13;
74. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Professional Edition e-book. Netherlands: Elsevier Health Sciences; 2014.&#13;
75. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012;76:16-32.&#13;
76. Oon SF, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Sa’ariwijaya MS, et al. Xanthorrhizol: A review of its pharmacological activities and anticancer properties. Cancer Cell Int 2015;15:100.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>